Thursday, November 8, 2018
Perrigo cuts FY18 adj. EPS view to $4.45-$4.65 from $4.75-$4.95, consensus $4.74
Reduces FY18 revenue approximately $4.72B, consensus $4.85B. The reduction in FY18 adjusted EPSS is primarily due to revised expectation in the RX segment. In addition, reduced margin expectations in the CHC Americas segment are expected to be partially offset by improved margin expectations in the CHC International segment.
https://thefly.com/landingPageNews.php?id=2820201
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.